Urology · Chicago, IL
NPI
1639601644
Since 2017
Specialty
Urology
Code 390200000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1013 S Laflin St, Apartment 2
Chicago, IL, 60607
Phone (414) 805-0788
Groups this clinician bills Medicare through
Medicare paid, 2024
$79K
750 services
Medicare patients, 2024
251
Average age 73
Drug cost, 2024
$42K
518 prescriptions
Company payments, 2025
$252
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Robert Medairos was code 99214 (office e&m - established), 130 times for 95 patients. In total Robert Medairos billed 750 services in 43 codes, and Medicare paid $79K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-10-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 130 | 95 | $74.03 | $9,624 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 93 | 75 | $13.00 | $1,209 |
| 74420 Standard X-ray | Facility | 69 | 55 | $19.44 | $1,341 |
| 99213 Office E&M - Established | Facility | 69 | 61 | $44.71 | $3,085 |
| 52000 Cystourethroscopy | Facility | 67 | 66 | $55.93 | $3,747 |
| 52332 Cystourethroscopy | Facility | 51 | 37 | $91.65 | $4,674 |
| 99204 Office E&M - New | Facility | 46 | 46 | $96.43 | $4,436 |
| 52310 Calculus Removal - Urinary | Facility | 24 | 24 | $113.49 | $2,724 |
| 50437 Other Organ Systems | Facility | 24 | 21 | $100.66 | $2,416 |
| 50081 Other Organ Systems | Facility | 22 | 19 | $926.43 | $20K |
| 52356 Calculus Removal - Urinary | Facility | 19 | 19 | $290.54 | $5,520 |
| 99233 Hospital E&M - Subsequent | Facility | 19 | 12 | $88.82 | $1,687 |
| 52351 Cystourethroscopy | Facility | 13 | 12 | $172.58 | $2,244 |
| 99222 Hospital E&M - Initial | Facility | 11 | 11 | $96.61 | $1,063 |
By year: 2022 $5,113 for 46 services; 2023 $41K for 426 services; 2024 $79K for 750 services.
Medicare prescription drug claims, 2024
In 2024, the drug Robert Medairos prescribed most often to Medicare patients was Potassium Citrate Er (Potassium Citrate), with 126 prescriptions and refills. In total Robert Medairos wrote 518 Medicare prescriptions that cost $42K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Potassium Citrate Er Potassium Citrate | 126 | 339 | 45 | $19K |
| Tamsulosin Hcl Generic | 84 | 170 | 30 | $967 |
| Chlorthalidone Generic | 44 | 132 | 14 | $595 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 39 | 39 | 33 | $219 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 22 | 26 | 20 | $102 |
| Cephalexin Generic | 18 | 23 | 14 | $85.63 |
| Finasteride Generic | 16 | 46 | Under 11 | $243 |
| Myrbetriq Mirabegron | 15 | 29 | Under 11 | $13K |
| Estradiol Generic | 14 | 26 | Under 11 | $830 |
| Indapamide Generic | 14 | 30 | Under 11 | $147 |
| Klor-Con-Ef Potassium Bicarbonate/Cit Ac | 13 | 15 | Under 11 | $1,046 |
| Tadalafil Generic | 13 | 15 | Under 11 | $94.25 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 11 | 21 | Under 11 | $263 |
Brand drugs: 45 claims; generic drugs: 460 claims; opioid claims: 11.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Robert Medairos $252 ($252 in general payments such as food, travel and fees) from 2 companies. The largest payer was Boston Scientific Corporation with $127.
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation BSX | 1 | $127 |
| Calyxo, Inc. | 1 | $125 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.